CLINICAL TRIAL PARTICIPATION Senate SponsorsSen. Adriane Johnson, Laura M. Murphy, Linda Holmes, Paul Faraci, Cristina Castro, Willie Preston, Mary Edly-Allen and Sara Feigenholtz House Sponsors(Rep. Camille Y. Lilly-Edgar Gonzalez, Jr. and Margaret Croke) 6/30/2023SenatePublic Act . . . . . . . . . 103-0227 410 ILCS 416/1410 ILCS 416/5410 ILCS 416/10410 ILCS 416/15410 ILCS 416/20410 ILCS 416/25410 ILCS 416/30Amends the Cancer Clinical Trial Participation Program Act. Changes the short title of the Act to the Clinical Trial Participation Program Act. Throughout the Act, replaces references to "cancer clinical trial" with references to "clinical trial" and makes conforming changes. Provides that "clinical trial" includes a voluntary research study conducted on people and designed to answer specific questions about the safety or effectiveness of a drug, vaccine, therapy, medical device, medical diagnostic, or new way of using an existing treatment to treat or diagnose a condition. Defines "condition". Makes other changes. Effective immediately. 2/9/2023SenateFiled with Secretary by Sen. Adriane Johnson 2/9/2023SenateFirst Reading 2/9/2023SenateReferred to Assignments 2/15/2023SenateAdded as Co-Sponsor Sen. Laura M. Murphy 2/21/2023SenateAssigned to Public Health 2/27/2023SenateAdded as Co-Sponsor Sen. Linda Holmes 3/3/2023SenateAdded as Co-Sponsor Sen. Paul Faraci 3/7/2023SenateAdded as Co-Sponsor Sen. Cristina Castro 3/8/2023SenateDo Pass Public Health; 007-000-000 3/8/2023SenatePlaced on Calendar Order of 2nd Reading March 9, 2023 3/8/2023SenateAdded as Co-Sponsor Sen. Willie Preston 3/10/2023SenateSecond Reading 3/10/2023SenatePlaced on Calendar Order of 3rd Reading March 21, 2023 3/13/2023SenateAdded as Co-Sponsor Sen. Mary Edly-Allen 3/23/2023SenatePlaced on Calendar Order of 3rd Reading ** March 24, 2023 3/28/2023SenateAdded as Co-Sponsor Sen. Sara Feigenholtz 3/29/2023SenateThird Reading - Passed; 057-000-000 3/30/2023HouseArrived in House 3/30/2023HouseChief House Sponsor Rep. Camille Y. Lilly 3/30/2023HouseFirst Reading 3/30/2023HouseReferred to Rules Committee 4/18/2023HouseAssigned to Appropriations-Health & Human Services Committee 4/26/2023HouseCommittee/Final Action Deadline Extended-9(b) May 19, 2023 4/27/2023HouseAdded Alternate Chief Co-Sponsor Rep. Edgar Gonzalez, Jr. 5/3/2023HouseMotion Filed to Suspend Rule 21 Human Services Committee; Rep. Robyn Gabel 5/3/2023HouseMotion to Suspend Rule 21 - Prevailed 071-040-000 5/3/2023HouseAdded Alternate Co-Sponsor Rep. Margaret Croke 5/4/2023HouseDo Pass / Short Debate Appropriations-Health & Human Services Committee; 023-000-000 5/4/2023HousePlaced on Calendar 2nd Reading - Short Debate 5/10/2023HouseSecond Reading - Short Debate 5/10/2023HousePlaced on Calendar Order of 3rd Reading - Short Debate 5/11/2023HouseThird Reading - Short Debate - Passed 111-000-000 5/11/2023SenatePassed Both Houses 6/9/2023SenateSent to the Governor 6/30/2023SenateGovernor Approved 6/30/2023SenateEffective Date June 30, 2023 6/30/2023SenatePublic Act . . . . . . . . . 103-0227